{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:34:32Z","timestamp":1792089272884,"version":"4.4.0"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.trsl.2024.09.001","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T04:03:31Z","timestamp":1725941011000},"page":"35-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Diagnostic, prognostic, and predictive biomarkers in gastric cancer: from conventional to novel biomarkers"],"prefix":"10.1016","volume":"274","author":[{"given":"Ghazaleh","family":"Khalili-Tanha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Khalili-Tanha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arian Karimi","family":"Rouzbahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramisa","family":"Mahdieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Jasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Ghaderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Khojasteh","family":"Leylakoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Khazaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mahdi","family":"Hassanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Saeed","family":"Gataa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A","family":"Ferns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Avan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"Can Cancer J Clin"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0002","first-page":"17","article-title":"Significant function and research progress of biomarkers in gastric cancer","volume":"19","author":"Ye","year":"2020","journal-title":"Oncol Lett"},{"key":"10.1016\/j.trsl.2024.09.001_bib0003","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.crad.2018.07.115","article-title":"Diagnostic efficacy of the barium swallow","volume":"73","author":"Black","year":"2018","journal-title":"Clin Radiol"},{"issue":"7","key":"10.1016\/j.trsl.2024.09.001_bib0004","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/bjs.1800740728","article-title":"Accuracy of identification of early gastric cancer","volume":"74","author":"Ballantyne","year":"1987","journal-title":"J British Surg"},{"issue":"10","key":"10.1016\/j.trsl.2024.09.001_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700448","article-title":"Discovery and validation of clinical biomarkers of cancer: a review combining metabolomics and proteomics","volume":"19","author":"Srivastava","year":"2019","journal-title":"Proteomics"},{"issue":"224","key":"10.1016\/j.trsl.2024.09.001_bib0006","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early-and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"issue":"17","key":"10.1016\/j.trsl.2024.09.001_bib0007","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3748\/wjg.v25.i17.2029","article-title":"Recent advances in gastric cancer early diagnosis","volume":"25","author":"Necula","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.trsl.2024.09.001_bib0008","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000510489","article-title":"Biomarkers for precision treatment in gastric cancer","volume":"36","author":"Petrillo","year":"2020","journal-title":"Visc Med"},{"issue":"3","key":"10.1016\/j.trsl.2024.09.001_bib0009","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.trsl.2024.09.001_bib0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","article-title":"Biomarkers: potential uses and limitations","volume":"1","author":"Mayeux","year":"2004","journal-title":"NeuroRx"},{"issue":"3","key":"10.1016\/j.trsl.2024.09.001_bib0011","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3892\/mco.2015.712","article-title":"Differences and correlation of serum CEA, CA19-9 and CA72-4 in gastric cancer","volume":"4","author":"Yu","year":"2016","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0012","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ueg2.12328","article-title":"Gastric cancer detection by non-blood-based liquid biopsies: A systematic review looking into the last decade of research","volume":"11","author":"Lopes","year":"2023","journal-title":"United European Gastroenterol J"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0013","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/bjc.1993.300","article-title":"Expression of carcinoembryonic antigen (CEA) and nonspecific crossreacting antigen (NCA) in gastrointestinal cancer; the correlation with degree of differentiation","volume":"68","author":"Kodera","year":"1993","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.trsl.2024.09.001_bib0014","doi-asserted-by":"crossref","first-page":"488","DOI":"10.52547\/rbmb.10.3.488","article-title":"Irisin and carcinoembryonic antigen (CEA) as potential diagnostic biomarkers in gastric and colorectal cancers","volume":"10","author":"Abd Temur","year":"2021","journal-title":"Rep Biochem Mol Biol"},{"key":"10.1016\/j.trsl.2024.09.001_bib0015","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.2147\/OTT.S245178","article-title":"Review of research on the role of irisin in tumors","author":"Zhang","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"24","key":"10.1016\/j.trsl.2024.09.001_bib0016","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.7150\/thno.33858","article-title":"Carcinoembryonic antigen carrying SLeX as a new biomarker of more aggressive gastric carcinomas","volume":"9","author":"Gomes","year":"2019","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.trsl.2024.09.001_bib0017","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.7150\/jca.67600","article-title":"Prognostic value of the combination of HB (hemoglobin) and CEA in resectable gastric cancer","volume":"13","author":"Qiu","year":"2022","journal-title":"J Cancer"},{"issue":"2","key":"10.1016\/j.trsl.2024.09.001_bib0018","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000445765","article-title":"Analyzing gastric lavage of gastric cancer patients: a prospective observational study on cytopathology and determination of intragastric CEA, CA 19.9, CA 72.4, and CA 50","volume":"60","author":"Virgilio","year":"2016","journal-title":"Acta Cytol"},{"key":"10.1016\/j.trsl.2024.09.001_bib0019","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-94-017-7215-0_15","article-title":"CA 19-9: biochemical and clinical aspects","author":"Scar\u00e0","year":"2015","journal-title":"Adv Cancer Biomarkers"},{"issue":"15","key":"10.1016\/j.trsl.2024.09.001_bib0020","doi-asserted-by":"crossref","first-page":"12192","DOI":"10.3390\/ijms241512192","article-title":"Using normalized carcinoembryonic antigen and carbohydrate antigen 19 to predict and monitor the efficacy of neoadjuvant chemotherapy in locally advanced gastric cancer","volume":"24","author":"Tang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.trsl.2024.09.001_bib0021","first-page":"1759","article-title":"Combination of HCGbeta, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies","volume":"22","author":"Louhimo","year":"2002","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-022-09482-8","article-title":"CA19-9 in combination with P-CRP as a predictive marker of immune-related adverse events in patients with recurrent or unresectable advanced gastric cancer treated with nivolumab","volume":"22","author":"Matsunaga","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.trsl.2024.09.001_bib0023","doi-asserted-by":"crossref","first-page":"8087","DOI":"10.2147\/IJGM.S335985","article-title":"Gastrin-17 combined with CEA, CA12-5 and CA19-9 improves the sensitivity for the diagnosis of gastric cancer","author":"Wang","year":"2021","journal-title":"Int J Gen Med"},{"issue":"10","key":"10.1016\/j.trsl.2024.09.001_bib0024","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.3390\/cancers12102904","article-title":"Screening for early gastric cancer using a noninvasive urine metabolomics approach","volume":"12","author":"Kwon","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.trsl.2024.09.001_bib0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/172460089501000206","article-title":"Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer","volume":"10","author":"Safi","year":"1995","journal-title":"Int J Biol Markers"},{"issue":"2","key":"10.1016\/j.trsl.2024.09.001_bib0026","doi-asserted-by":"crossref","first-page":"186","DOI":"10.25122\/jml-2022-0173","article-title":"The importance of CA 72-4 and CA 19-9 dosing in gastric cancer","volume":"16","author":"Ro\u0219u","year":"2023","journal-title":"J Med Life"},{"key":"10.1016\/j.trsl.2024.09.001_bib0027","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0041-87812002000300001","article-title":"Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer","volume":"57","author":"Mattar","year":"2002","journal-title":"Revista do Hospital das Cl\u00ednicas"},{"key":"10.1016\/j.trsl.2024.09.001_bib0028","doi-asserted-by":"crossref","unstructured":"Sun L, Sun Y, Zhao L, et al. Serum CST4 combined with CEA, CA72-4, CA125, CA19-9 improves the diagnosis value of gastric cancer and changes in pre-operation and post-operation. 2023.","DOI":"10.21203\/rs.3.rs-3168804\/v1"},{"issue":"3","key":"10.1016\/j.trsl.2024.09.001_bib0029","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.21037\/jgo-21-254","article-title":"Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer","volume":"12","author":"Lin","year":"2021","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"10.1016\/j.trsl.2024.09.001_bib0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3748\/wjg.v24.i2.266","article-title":"Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum","volume":"24","author":"Wang","year":"2018","journal-title":"AFP. World J Gastroenterol"},{"issue":"60","key":"10.1016\/j.trsl.2024.09.001_bib0031","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.22109","article-title":"Novel characteristics of alpha-fetoprotein (AFP)-producing gastric cancer","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"issue":"23","key":"10.1016\/j.trsl.2024.09.001_bib0032","doi-asserted-by":"crossref","first-page":"12016","DOI":"10.18632\/oncotarget.2434","article-title":"Role of p53 in the progression of gastric cancer","volume":"5","author":"Busuttil","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.trsl.2024.09.001_bib0033","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00432-014-1844-7","article-title":"The prognostic significance of p53 expression in gastric cancer: a meta-analysis","volume":"141","author":"Wei","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"10.1016\/j.trsl.2024.09.001_bib0034","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41416-021-01271-7","article-title":"Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53\u2013Bcl-2 intrinsic apoptosis pathway","volume":"124","author":"Miwa","year":"2021","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.trsl.2024.09.001_bib0035","doi-asserted-by":"crossref","first-page":"e90155","DOI":"10.1371\/journal.pone.0090155","article-title":"A Compensatory role of NF-\u03baB to p53 in response to 5-FU\u2013based chemotherapy for gastric cancer cell lines","volume":"9","author":"Endo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2024.09.001_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1203980","article-title":"Expression of p53 as a biomarker in determining response to apatinib for advanced gastric cancer","volume":"13","author":"Qiu","year":"2023","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.trsl.2024.09.001_bib0037","doi-asserted-by":"crossref","first-page":"e95371","DOI":"10.1371\/journal.pone.0095371","article-title":"Relationship between p53 status and response to chemotherapy in patients with gastric cancer: a meta-analysis","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"issue":"31","key":"10.1016\/j.trsl.2024.09.001_bib0038","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.3748\/wjg.v25.i31.4452","article-title":"High expression of APC is an unfavorable prognostic biomarker in T4 gastric cancer patients","volume":"25","author":"Du","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"16","key":"10.1016\/j.trsl.2024.09.001_bib0039","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019828","article-title":"Association of APC gene promoter methylation and the risk of gastric cancer: a meta-analysis and bioinformatics study","volume":"99","author":"Zhou","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"14","key":"10.1016\/j.trsl.2024.09.001_bib0040","doi-asserted-by":"crossref","first-page":"R626","DOI":"10.1016\/j.cub.2013.06.019","article-title":"Three functions of cadherins in cell adhesion","volume":"23","author":"Ma\u00eetre","year":"2013","journal-title":"Curr Biol"},{"key":"10.1016\/j.trsl.2024.09.001_bib0041","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s10120-015-0495-y","article-title":"Osteopontin, E-cadherin, and \u03b2-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer","volume":"19","author":"Di Bartolomeo","year":"2016","journal-title":"Gastric Cancer"},{"issue":"11","key":"10.1016\/j.trsl.2024.09.001_bib0042","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/ijc.27947","article-title":"The prognostic value of E-cadherin in gastric cancer: a meta-analysis","volume":"132","author":"Xing","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trsl.2024.09.001_bib0043","first-page":"1","article-title":"Integrin \u03b21 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells","author":"Figueiredo","year":"2022","journal-title":"Gastric Cancer"},{"issue":"22","key":"10.1016\/j.trsl.2024.09.001_bib0044","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.7150\/jca.30074","article-title":"Ki-67\/MKI67 as a predictive biomarker for clinical outcome in gastric cancer patients: an updated meta-analysis and systematic review involving 53 studies and 7078 patients","volume":"10","author":"Xiong","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.trsl.2024.09.001_bib0045","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.2147\/OTT.S143089","article-title":"Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression in gastric cancer: a systematic review and meta-analysis","author":"Liu","year":"2017","journal-title":"Onco Targets Ther"},{"issue":"30","key":"10.1016\/j.trsl.2024.09.001_bib0046","doi-asserted-by":"crossref","first-page":"50273","DOI":"10.18632\/oncotarget.17305","article-title":"Clinicopathologic significance and prognostic value of Ki-67 expression in patients with gastric cancer: a meta-analysis","volume":"8","author":"Luo","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.trsl.2024.09.001_bib0047","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejso.2012.08.023","article-title":"Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma","volume":"39","author":"He","year":"2013","journal-title":"Eur J Surg Oncol (EJSO)"},{"issue":"3","key":"10.1016\/j.trsl.2024.09.001_bib0048","doi-asserted-by":"crossref","first-page":"255","DOI":"10.31557\/apjcb.2022.7.3.255-263","article-title":"CDX2 and Ki-67 expression in gastric carcinoma and its association with clinocopathological parameters","volume":"7","author":"Pranjali","year":"2022","journal-title":"Asian Pacific J Cancer Biol"},{"issue":"9","key":"10.1016\/j.trsl.2024.09.001_bib0049","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/annonc\/mdn169","article-title":"HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target","volume":"19","author":"Gravalos","year":"2008","journal-title":"Annals Oncol"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-022-02309-7","article-title":"Relationship between HER2 overexpression and long-term outcomes of early gastric cancer: a prospective observational study with a 6-year follow-up","volume":"22","author":"Li","year":"2022","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0051","first-page":"301","article-title":"Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer","volume":"34","author":"Palacio","year":"2014","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.trsl.2024.09.001_bib0052","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/bjc.2014.18","article-title":"Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)","volume":"110","author":"Kurokawa","year":"2014","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.trsl.2024.09.001_bib0053","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/1078-0432.CCR-17-2781","article-title":"Biomarkers of primary resistance to trastuzumab in HER2-positive metastatic gastric cancer patients: the AMNESIA case-control study","volume":"24","author":"Pietrantonio","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0054","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1186\/s12885-022-10262-7","article-title":"Prognostic and clinical significance of HER-2 low expression in early-stage gastric cancer","volume":"22","author":"Yang","year":"2022","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5322-0","article-title":"VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer","volume":"19","author":"Lian","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.trsl.2024.09.001_bib0056","first-page":"586","article-title":"Overexpression of both VEGF-A and VEGF-C in gastric cancer correlates with prognosis, and silencing of both is effective to inhibit cancer growth","volume":"6","author":"Wang","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"issue":"24","key":"10.1016\/j.trsl.2024.09.001_bib0057","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.3748\/wjg.14.3879","article-title":"Measurement of circulating levels of VEGF-A,-C, and-D and their receptors, VEGFR-1 and-2 in gastric adenocarcinoma","volume":"14","author":"Al-Moundhri","year":"2008","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.trsl.2024.09.001_bib0058","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejca.2019.10.026","article-title":"Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study","volume":"127","author":"Van Cutsem","year":"2020","journal-title":"Eur J Cancer (1965)"},{"key":"10.1016\/j.trsl.2024.09.001_bib0059","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.4_suppl.437","article-title":"CA125 kinetics as a potential biomarker for ascites progression during taxane plus ramucirumab therapy in patients with advanced gastric cancer","author":"Ueda","year":"2023","journal-title":"Am Soc Clin Oncol"},{"issue":"7","key":"10.1016\/j.trsl.2024.09.001_bib0060","first-page":"3347","article-title":"Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer","volume":"12","author":"Fornaro","year":"2022","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.trsl.2024.09.001_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-8-45","article-title":"The endothelial lipase protein is promising urinary biomarker for diagnosis of gastric cancer","volume":"8","author":"Dong","year":"2013","journal-title":"Diagn Pathol"},{"issue":"5","key":"10.1016\/j.trsl.2024.09.001_bib0062","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0063","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1038\/srep10154","article-title":"Hypermethylated Epidermal growth factor receptor (EGFR) promoter is associated with gastric cancer","volume":"5","author":"Weng","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0064","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1038\/srep02992","article-title":"A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy","volume":"3","author":"Zhang","year":"2013","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.trsl.2024.09.001_bib0065","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.3892\/or.2017.5907","article-title":"EGFR gene status predicts response and survival benefit in a preclinical gastric cancer trial treating patient\u2011derived xenografts with cetuximab","volume":"38","author":"Wang","year":"2017","journal-title":"Oncol Rep"},{"issue":"2","key":"10.1016\/j.trsl.2024.09.001_bib0066","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317691681","article-title":"Dynamic tracing for epidermal growth factor receptor mutations in urinary circulating DNA in gastric cancer patients","volume":"39","author":"Shi","year":"2017","journal-title":"Tumor Biol"},{"issue":"47","key":"10.1016\/j.trsl.2024.09.001_bib0067","doi-asserted-by":"crossref","first-page":"8291","DOI":"10.3748\/wjg.v23.i47.8291","article-title":"Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing","volume":"23","author":"Youssef","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"1_suppl","key":"10.1016\/j.trsl.2024.09.001_bib0068","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/1758834011422556","article-title":"An overview of the c-MET signaling pathway","volume":"3","author":"Organ","year":"2011","journal-title":"Ther Adv Med Oncol"},{"issue":"3","key":"10.1016\/j.trsl.2024.09.001_bib0069","first-page":"242","article-title":"Dysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistance","volume":"4","author":"Sacco","year":"2015","journal-title":"Transl Lung Cancer Res"},{"issue":"5","key":"10.1016\/j.trsl.2024.09.001_bib0070","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/028418601750444204","article-title":"Overexpression of the c-met protooncogene in human gastric carcinoma-correlation to clinical features","volume":"40","author":"Huang","year":"2001","journal-title":"Acta Oncol (Madr)"},{"issue":"6","key":"10.1016\/j.trsl.2024.09.001_bib0071","first-page":"1477","article-title":"The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation","volume":"19","author":"Drebber","year":"2008","journal-title":"Oncol Rep"},{"issue":"6","key":"10.1016\/j.trsl.2024.09.001_bib0072","first-page":"1517","article-title":"Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target","volume":"25","author":"Lee","year":"2011","journal-title":"Oncol Rep"},{"issue":"10","key":"10.1016\/j.trsl.2024.09.001_bib0073","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1038\/bjc.2013.638","article-title":"A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma","volume":"109","author":"Yashiro","year":"2013","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0074","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-016-2058-y","article-title":"Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells","volume":"16","author":"Park","year":"2016","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.trsl.2024.09.001_bib0075","first-page":"727","article-title":"PD-1\/PD-L1 pathway: current researches in cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0076","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pbj.2016.03.004","article-title":"The PD-1: PD-L1 immune inhibitory checkpoint in Helicobacter pylori infection and gastric cancer: a comprehensive review and future perspectives","volume":"1","author":"Silva","year":"2016","journal-title":"Porto Biomed J"},{"key":"10.1016\/j.trsl.2024.09.001_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121865","article-title":"Dual targeting of TGF-\u03b2 and PD-L1 inhibits tumor growth in TGF-\u03b2\/PD-L1-driven colorectal carcinoma","author":"Khalili-Tanha","year":"2023","journal-title":"Life Sci"},{"issue":"13","key":"10.1016\/j.trsl.2024.09.001_bib0078","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1084\/jem.20161462","article-title":"What does PD-L1 positive or negative mean?","volume":"213","author":"Ribas","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2024.09.001_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153390","article-title":"Programmed cell death 1 as prognostic marker and therapeutic target in upper gastrointestinal cancers","volume":"220","author":"Khoshghamat","year":"2021","journal-title":"Pathol-Res Practice"},{"key":"10.1016\/j.trsl.2024.09.001_bib0080","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10120-020-01151-8","article-title":"Combined inhibition of PD-1\/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer\u2013T cell coculture models","volume":"24","author":"Mimura","year":"2021","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.trsl.2024.09.001_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107443","article-title":"PD-1\/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K\/AKT mediated P-gp expression","volume":"94","author":"Wu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.trsl.2024.09.001_bib0082","article-title":"The prognostic value of gastric immune prognostic index in gastric cancer patients treated with PD-1\/PD-L1 inhibitors","volume":"13","author":"Chen","year":"2022","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.trsl.2024.09.001_bib0083","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.dld.2022.01.128","article-title":"PD-L1 and HER2 expression in gastric adenocarcinoma and their prognostic significance","volume":"54","author":"Lian","year":"2022","journal-title":"Digestive Liver Dis"},{"issue":"3","key":"10.1016\/j.trsl.2024.09.001_bib0084","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3390\/cancers12030695","article-title":"Emerging role of circulating tumor cells in gastric cancer","volume":"12","author":"Thanh Huong","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.trsl.2024.09.001_bib0085","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2174\/1568009621666210311090531","article-title":"The clinical application of circulating tumor cells and DNAs as prognostic and predictive biomarkers in gastrointestinal cancer","volume":"21","author":"Memarpour","year":"2021","journal-title":"Curr Cancer Drug Targets"},{"issue":"10","key":"10.1016\/j.trsl.2024.09.001_bib0086","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2174\/1381612829666230308102611","article-title":"Circulating Tumor Cells and Cell-free Nucleic Acids as Biomarkers in Colorectal Cancer","volume":"29","author":"Pourali","year":"2023","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0087","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-13-314","article-title":"Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and meta-analysis","volume":"13","author":"Tang","year":"2013","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.trsl.2024.09.001_bib0088","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180251","article-title":"Circulating tumor cells detected by lab-on-a-disc: Role in early diagnosis of gastric cancer","volume":"12","author":"Kang","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0089","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ijc.28954","article-title":"Clinicopathological and prognostic significance of circulating tumor cells in patients with gastric cancer: a meta-analysis","volume":"136","author":"Huang","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trsl.2024.09.001_bib0090","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1245\/s10434-015-4483-6","article-title":"Circulating tumor cells as an independent predictor of survival in advanced gastric cancer","volume":"22","author":"Okabe","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.trsl.2024.09.001_bib0091","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bjc.2015.417","article-title":"Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer","volume":"114","author":"Li","year":"2016","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.trsl.2024.09.001_bib0092","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3892\/mco.2017.1125","article-title":"Prognostic value of circulating tumor cells in advanced gastric cancer patients receiving chemotherapy","volume":"6","author":"Liu","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.trsl.2024.09.001_bib0093","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.4_suppl.59","article-title":"Prognostic significance of circulating tumor cells in patients with gastric cancer: epithelial mesenchymal transition and perioperative kinetics","author":"Ishiguro","year":"2019","journal-title":"Am Soc Clin Oncol"},{"key":"10.1016\/j.trsl.2024.09.001_bib0094","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00432-014-1814-0","article-title":"Isolation and characterization of circulating tumor cells from human gastric cancer patients","volume":"141","author":"Yuan","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.trsl.2024.09.001_bib0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11523-017-0493-6","article-title":"Detection of HER2 amplification in circulating tumor cells of HER2-negative gastric cancer patients","volume":"12","author":"Mishima","year":"2017","journal-title":"Target Oncol"},{"issue":"8","key":"10.1016\/j.trsl.2024.09.001_bib0096","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3390\/cells8080809","article-title":"Circulating tumor cell PD-L1 expression as biomarker for therapeutic efficacy of immune checkpoint inhibition in NSCLC","volume":"8","author":"Kloten","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0097","doi-asserted-by":"crossref","first-page":"47","DOI":"10.29252\/ibj.24.1.47","article-title":"Correlation of HER2, MDM2, c-MYC, c-MET, and TP53 copy number alterations in circulating tumor cells with tissue in gastric cancer patients: a pilot study","volume":"24","author":"Nevisi","year":"2020","journal-title":"Iran Biomed J"},{"issue":"4","key":"10.1016\/j.trsl.2024.09.001_bib0098","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41416-022-01776-9","article-title":"Integrating circulating-free DNA (cfDNA) analysis into clinical practice: Opportunities and challenges","volume":"127","author":"Garcia-Pardo","year":"2022","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.trsl.2024.09.001_bib0099","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4174\/astr.2014.86.3.136","article-title":"Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection","volume":"86","author":"Kim","year":"2014","journal-title":"Ann Surg Treat Res"},{"issue":"6","key":"10.1016\/j.trsl.2024.09.001_bib0100","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/cam4.3755","article-title":"Methylation status and long-fragment cell-free DNA are prognostic biomarkers for gastric cancer","volume":"10","author":"Ko","year":"2021","journal-title":"Cancer Med"},{"issue":"9","key":"10.1016\/j.trsl.2024.09.001_bib0101","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1136\/gutjnl-2020-322658","article-title":"EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers","volume":"70","author":"Smyth","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2024.09.001_bib0102","first-page":"2022","article-title":"Application of circulating tumor cells and circulating free DNA from peripheral blood in the prognosis of advanced gastric cancer","author":"Yu","year":"2022","journal-title":"J Oncol"},{"issue":"2","key":"10.1016\/j.trsl.2024.09.001_bib0103","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/clinchem\/hvab204","article-title":"Genome-scale methylation analysis of circulating cell-free DNA in gastric cancer patients","volume":"68","author":"Ren","year":"2022","journal-title":"Clin Chem"},{"key":"10.1016\/j.trsl.2024.09.001_bib0104","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2017.10.032","article-title":"HER2 copy number of circulating tumour DNA functions as a biomarker to predict and monitor trastuzumab efficacy in advanced gastric cancer","volume":"88","author":"Wang","year":"2018","journal-title":"Eur J Cancer (1965)"},{"issue":"9","key":"10.1016\/j.trsl.2024.09.001_bib0105","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3349\/ymj.2023.0096","article-title":"Monitoring the outcomes of systemic chemotherapy including immune checkpoint inhibitor for HER2-positive metastatic gastric cancer by liquid biopsy","volume":"64","author":"Jung","year":"2023","journal-title":"Yonsei Med J"},{"issue":"34","key":"10.1016\/j.trsl.2024.09.001_bib0106","doi-asserted-by":"crossref","first-page":"12007","DOI":"10.3748\/wjg.v20.i34.12007","article-title":"MicroRNAs as potential biomarkers for gastric cancer","volume":"20","author":"Liu","year":"2014","journal-title":"World J Gastroenterol: WJG"},{"issue":"8","key":"10.1016\/j.trsl.2024.09.001_bib0107","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.ejca.2012.12.017","article-title":"miR-17-5p\/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation","volume":"49","author":"Wang","year":"2013","journal-title":"Eur J Cancer (1965)"},{"issue":"3","key":"10.1016\/j.trsl.2024.09.001_bib0108","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbrc.2009.12.182","article-title":"MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2","volume":"392","author":"Wu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"14","key":"10.1016\/j.trsl.2024.09.001_bib0109","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/sj.onc.1206222","article-title":"EGR2 induces apoptosis in various cancer cell lines by direct transactivation of BNIP3L and BAK","volume":"22","author":"Unoki","year":"2003","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.trsl.2024.09.001_bib0110","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.160","article-title":"miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer","volume":"3","author":"Sacconi","year":"2012","journal-title":"Cell Death Dis"},{"issue":"13","key":"10.1016\/j.trsl.2024.09.001_bib0111","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1158\/1078-0432.CCR-10-2866","article-title":"Clinical significance of miR-146a in gastric cancer cases","volume":"17","author":"Kogo","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.trsl.2024.09.001_bib0112","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3727\/096504012X13522227232156","article-title":"The identification of miR-375 as a potential biomarker in distal gastric adenocarcinoma","volume":"20","author":"Zhang","year":"2012","journal-title":"Oncol Res Featuring Preclin Clin Cancer Therapeutics"},{"key":"10.1016\/j.trsl.2024.09.001_bib0113","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s12032-009-9269-x","article-title":"Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance","volume":"27","author":"Zhang","year":"2010","journal-title":"Med Oncol"},{"issue":"2A","key":"10.1016\/j.trsl.2024.09.001_bib0114","first-page":"907","article-title":"miR-21 microRNA expression in human gastric carcinomas and its clinical association","volume":"28","author":"Chan","year":"2008","journal-title":"Anticancer Res"},{"issue":"1-2","key":"10.1016\/j.trsl.2024.09.001_bib0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cca.2008.10.021","article-title":"Detection of miR-106a in gastric carcinoma and its clinical significance","volume":"400","author":"Xiao","year":"2009","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.trsl.2024.09.001_bib0116","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00535-009-0135-6","article-title":"Increased expression of miR-421 in human gastric carcinoma and its clinical association","volume":"45","author":"Jiang","year":"2010","journal-title":"J Gastroenterol"},{"issue":"10","key":"10.1016\/j.trsl.2024.09.001_bib0117","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/annonc\/mdq758","article-title":"Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection","volume":"22","author":"Zhang","year":"2011","journal-title":"Annals Oncol"},{"issue":"7","key":"10.1016\/j.trsl.2024.09.001_bib0118","doi-asserted-by":"crossref","first-page":"e40037","DOI":"10.1371\/journal.pone.0040037","article-title":"Identification of hsa-miR-335 as a prognostic signature in gastric cancer","volume":"7","author":"Yan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2024.09.001_bib0119","article-title":"The role of microRNA-21 (miR-21) in pathogenesis, diagnosis, and prognosis of gastrointestinal cancers: a review","author":"Far","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.trsl.2024.09.001_bib0120","article-title":"Mechanisms of action and clinical implications of microRNAs in the drug resistance of gastric cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.trsl.2024.09.001_bib0121","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bbrc.2020.05.135","article-title":"miR-149 contributes to resistance of 5-FU in gastric cancer via targeting TREM2 and regulating \u03b2-catenin pathway","volume":"532","author":"Wang","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2024.09.001_bib0122","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.637470","article-title":"CMPK1 regulated by miR-130b attenuates response to 5-FU treatment in gastric cancer","volume":"11","author":"Chu","year":"2021","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.trsl.2024.09.001_bib0123","article-title":"MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells","volume":"23","author":"Wang","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.trsl.2024.09.001_bib0124","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1159\/000490871","article-title":"Sensitization of gastric cancer cells to 5-FU by microRNA-204 through targeting the TGFBR2-mediated epithelial to mesenchymal transition","volume":"47","author":"Li","year":"2018","journal-title":"Cellular Physiol Biochem"},{"issue":"4","key":"10.1016\/j.trsl.2024.09.001_bib0125","first-page":"1855","article-title":"miR\u201121\u20115p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3","volume":"41","author":"Chen","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.trsl.2024.09.001_bib0126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: metabolism, functions and interactions with proteins","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.trsl.2024.09.001_bib0127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1069-0","article-title":"Biogenesis, functions and clinical significance of circRNAs in gastric cancer","volume":"18","author":"Shan","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.trsl.2024.09.001_bib0128","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s12253-019-00716-y","article-title":"Hsa_circ_0065149 is an indicator for early gastric cancer screening and prognosis prediction","volume":"26","author":"Shao","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.trsl.2024.09.001_bib0129","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.canlet.2016.12.006","article-title":"Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer","volume":"388","author":"Chen","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.trsl.2024.09.001_bib0130","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4587698","article-title":"Decreased expression of Hsa_circ_00001649 in gastric cancer and its clinical significance","author":"Li","year":"2017","journal-title":"Dis Markers"},{"key":"10.1016\/j.trsl.2024.09.001_bib0131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-0958-6","article-title":"CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p","volume":"18","author":"Rong","year":"2019","journal-title":"Mol Cancer"},{"issue":"3","key":"10.1016\/j.trsl.2024.09.001_bib0132","doi-asserted-by":"crossref","first-page":"e22726","DOI":"10.1002\/jcla.22726","article-title":"Hsa_circ_0000467 promotes cancer progression and serves as a diagnostic and prognostic biomarker for gastric cancer","volume":"33","author":"Lu","year":"2019","journal-title":"J Clin Lab Anal"},{"issue":"15","key":"10.1016\/j.trsl.2024.09.001_bib0133","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.3390\/cancers14153632","article-title":"Performance of salivary extracellular RNA biomarker panels for gastric cancer differs between distinct populations","volume":"14","author":"Kaczor-Urbanowicz","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.trsl.2024.09.001_bib0134","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1373\/clinchem.2018.290569","article-title":"Discovery and validation of salivary extracellular RNA biomarkers for noninvasive detection of gastric cancer","volume":"64","author":"Li","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.trsl.2024.09.001_bib0135","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00535-019-01601-w","article-title":"A novel urinary microRNA biomarker panel for detecting gastric cancer","volume":"54","author":"Iwasaki","year":"2019","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.trsl.2024.09.001_bib0136","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.steroids.2017.12.012","article-title":"Long noncoding RNAs and cancer, an overview","volume":"133","author":"Camacho","year":"2018","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11658-021-00282-9","article-title":"Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells","volume":"26","author":"Khalili-Tanha","year":"2021","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.trsl.2024.09.001_bib0138","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2147\/OTT.S68854","article-title":"Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer","author":"Ding","year":"2014","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.trsl.2024.09.001_bib0139","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3076345","article-title":"The association of HOTAIR with the diagnosis and prognosis of gastric cancer and its effect on the proliferation of gastric cancer cells","author":"Xu","year":"2019","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.trsl.2024.09.001_bib0140","first-page":"12936","article-title":"Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer","volume":"8","author":"Gao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.trsl.2024.09.001_bib0141","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1007\/s13277-014-1709-3","article-title":"Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance","volume":"35","author":"Pang","year":"2014","journal-title":"Tumor Biol"},{"key":"10.1016\/j.trsl.2024.09.001_bib0142","article-title":"Overexpression of lncRNAs H19 and UCA1 in gastric cancer tissues","volume":"27","author":"Alnajar","year":"2022","journal-title":"Gene Rep"},{"issue":"8","key":"10.1016\/j.trsl.2024.09.001_bib0143","doi-asserted-by":"crossref","first-page":"e23323","DOI":"10.1002\/jcla.23323","article-title":"Identification of serum exosomal lncRNA MIAT as a novel diagnostic and prognostic biomarker for gastric cancer","volume":"34","author":"Xu","year":"2020","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0144","first-page":"77","article-title":"LncRNA PTCSC3 is a biomarker for the treatment and prognosis of gastric cancer","volume":"35","author":"Zhang","year":"2020","journal-title":"Cancer Biother Radiopharm"},{"issue":"2","key":"10.1016\/j.trsl.2024.09.001_bib0145","doi-asserted-by":"crossref","first-page":"e24192","DOI":"10.1002\/jcla.24192","article-title":"LINC00152 acts as a competing endogenous RNA of HMGA1 to promote the growth of gastric cancer cells","volume":"36","author":"Chen","year":"2022","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0146","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12957-022-02760-6","article-title":"H19 may regulate the immune cell infiltration in carcinogenesis of gastric cancer through miR-378a-5p\/SERPINH1 signaling","volume":"20","author":"Li","year":"2022","journal-title":"World J Surg Oncol"},{"issue":"7","key":"10.1016\/j.trsl.2024.09.001_bib0147","first-page":"1295","article-title":"HOTAIR is a predictive and prognostic biomarker for patients with advanced gastric adenocarcinoma receiving fluorouracil and platinum combination chemotherapy","volume":"7","author":"Zhao","year":"2015","journal-title":"Am J Transl Res"},{"issue":"9","key":"10.1016\/j.trsl.2024.09.001_bib0148","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1002\/jcb.26901","article-title":"HOTAIR enhanced paclitaxel and doxorubicin resistance in gastric cancer cells partly through inhibiting miR-217 expression","volume":"119","author":"Wang","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.trsl.2024.09.001_bib0149","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00280-016-3029-3","article-title":"Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer","volume":"77","author":"Shang","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.trsl.2024.09.001_bib0150","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.12659\/MSM.900688","article-title":"Long non-coding RNA (LncRNA) urothelial carcinoma associated 1 (UCA1) increases multi-drug resistance of gastric cancer via downregulating miR-27b","volume":"22","author":"Fang","year":"2016","journal-title":"Med Sci Monitor: Int Med J Exp Clin Res"},{"issue":"12","key":"10.1016\/j.trsl.2024.09.001_bib0151","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/s41419-018-1170-0","article-title":"LncRNA UCA1 promotes tumor metastasis by inducing miR-203\/ZEB2 axis in gastric cancer","volume":"9","author":"Gong","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2024.09.001_bib0152","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.omtn.2018.05.024","article-title":"The long noncoding RNA D63785 regulates chemotherapy sensitivity in human gastric cancer by targeting miR-422a","volume":"12","author":"Zhou","year":"2018","journal-title":"Mol Ther-Nucleic Acids"},{"key":"10.1016\/j.trsl.2024.09.001_bib0153","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12253-017-0233-3","article-title":"Silence of long noncoding RNA NEAT1 inhibits malignant biological behaviors and chemotherapy resistance in gastric cancer","volume":"24","author":"Zhang","year":"2018","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.trsl.2024.09.001_bib0154","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104747","article-title":"Intestinal bacteria are potential biomarkers and therapeutic targets for gastric cancer","volume":"151","author":"Liu","year":"2021","journal-title":"Microb Pathog"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0155","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1038\/srep04202","article-title":"Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer","volume":"4","author":"Aviles-Jimenez","year":"2014","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.trsl.2024.09.001_bib0156","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1158\/1055-9965.EPI-13-0855","article-title":"Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach","volume":"23","author":"Yu","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"10.1016\/j.trsl.2024.09.001_bib0157","first-page":"530","article-title":"Gastric microbiota and carcinogenesis: the role of non-Helicobacter pylori bacteria: a systematic review","volume":"108","author":"Dias-J\u00e1come","year":"2016","journal-title":"Revista Espa\u00f1ola de Enfermedades Digestivas"},{"issue":"5","key":"10.1016\/j.trsl.2024.09.001_bib0158","first-page":"5615","article-title":"Analysis of correlation between HP infection and activation of PI3K\/Akt pathway in mucosal tissues of gastric cancer and precancerous lesions","volume":"16","author":"Xie","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.trsl.2024.09.001_bib0159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-14-179","article-title":"Occurrence of Helicobacter pylori and Epstein-Barr virus infection in endoscopic and gastric cancer patients from Northern Brazil","volume":"14","author":"de Souza","year":"2014","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1443-9573.2007.00271.x","article-title":"Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies","volume":"8","author":"Cao","year":"2007","journal-title":"J Dig Dis"},{"issue":"25","key":"10.1016\/j.trsl.2024.09.001_bib0161","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.3748\/wjg.v26.i25.3673","article-title":"Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area","volume":"26","author":"Yuan","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"30","key":"10.1016\/j.trsl.2024.09.001_bib0162","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.3748\/wjg.v28.i30.4120","article-title":"Salivary Fusobacterium nucleatum serves as a potential diagnostic biomarker for gastric cancer","volume":"28","author":"Chen","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0163","article-title":"Fecal microbiome alteration may be a potential marker for gastric cancer","volume":"2020","author":"Wu","year":"2020","journal-title":"Dis Markers"},{"issue":"6","key":"10.1016\/j.trsl.2024.09.001_bib0164","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02994-21","article-title":"Fecal streptococcus alteration is associated with gastric cancer occurrence and liver metastasis","volume":"12","author":"Yu","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.trsl.2024.09.001_bib0165","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00253-020-11043-7","article-title":"Gut microbiome analysis as a predictive marker for the gastric cancer patients","volume":"105","author":"Zhang","year":"2021","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.trsl.2024.09.001_bib0166","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.640309","article-title":"Salivary microbiota for gastric cancer prediction: an exploratory study","volume":"11","author":"Huang","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"16","key":"10.1016\/j.trsl.2024.09.001_bib0167","doi-asserted-by":"crossref","first-page":"e19828","DOI":"10.1097\/MD.0000000000019828","article-title":"Association of APC gene promoter methylation and the risk of gastric cancer: a meta-analysis and bioinformatics study","volume":"99","author":"Zhou","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0168","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12876-022-02309-7","article-title":"Relationship between HER2 overexpression and long-term outcomes of early gastric cancer: a prospective observational study with a 6-year follow-up","volume":"22","author":"Li","year":"2022","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"10.1016\/j.trsl.2024.09.001_bib0169","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/bjc.2014.18","article-title":"Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)","volume":"110","author":"Kurokawa","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.trsl.2024.09.001_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5322-0","article-title":"VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer","volume":"19","author":"Lian","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.trsl.2024.09.001_bib0171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-016-2058-y","article-title":"Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells","volume":"16","author":"Park","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.trsl.2024.09.001_bib0172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-13-314","article-title":"Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and meta-analysis","volume":"13","author":"Tang","year":"2013","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0173","article-title":"Application of circulating tumor cells and circulating free DNA from peripheral blood in the prognosis of advanced gastric cancer","volume":"2022","author":"Yu","year":"2022","journal-title":"J Oncol"},{"issue":"4","key":"10.1016\/j.trsl.2024.09.001_bib0174","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3727\/096504012X13522227232156","article-title":"The identification of miR-375 as a potential biomarker in distal gastric adenocarcinoma","volume":"20","author":"Zhang","year":"2012","journal-title":"Oncol Res"},{"key":"10.1016\/j.trsl.2024.09.001_bib0175","article-title":"The role of microRNA-21 (miR-21) in pathogenesis, diagnosis, and prognosis of gastrointestinal cancers: A review","volume":"316","author":"Far","year":"2023","journal-title":"Life Sci"},{"key":"10.1016\/j.trsl.2024.09.001_bib0176","doi-asserted-by":"crossref","unstructured":"Li W-h, Song Y-c, Zhang H, et al. Decreased expression of Hsa_circ_00001649 in gastric cancer and its clinical significance. Disease Markers. 2017;2017(1):4587698.","DOI":"10.1155\/2017\/4587698"},{"issue":"1","key":"10.1016\/j.trsl.2024.09.001_bib0177","article-title":"The association of HOTAIR with the diagnosis and prognosis of gastric cancer and its effect on the proliferation of gastric cancer cells","volume":"2019","author":"Xu","year":"2019","journal-title":"Can J Gastroenterol Hepatol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524424001671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524424001671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T15:36:32Z","timestamp":1731425792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524424001671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":177,"alternative-id":["S1931524424001671"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2024.09.001","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic, prognostic, and predictive biomarkers in gastric cancer: from conventional to novel biomarkers","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2024.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}